These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 18268280)

  • 1. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
    Moi P; Sadelain M
    Haematologica; 2008 Mar; 93(3):325-30. PubMed ID: 18310536
    [No Abstract]   [Full Text] [Related]  

  • 7. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
    Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
    J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
    May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M
    Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
    Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
    Morianos I; Siapati EK; Pongas G; Vassilopoulos G
    Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanized mouse model for a common beta0-thalassemia mutation.
    Jamsai D; Zaibak F; Khongnium W; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2005 Apr; 85(4):453-61. PubMed ID: 15780748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position-independent human beta-globin gene expression mediated by a recombinant adeno-associated virus vector carrying the chicken beta-globin insulator.
    Inoue T; Yamaza H; Sakai Y; Mizuno S; Ohno M; Hamasaki N; Fukumaki Y
    J Hum Genet; 1999; 44(3):152-62. PubMed ID: 10319578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
    Wang B; Fang Y; Guo X; Ren Z; Zhang J
    Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.